- active not recruitingPHASE2
A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AML
This study looks at a new combination treatment for adults with a type of blood cancer called AML that has come back or not responded to previous treatment. It aims to see if adding gilteritinib to standard drugs is safe and works better.
France - ongoing, recruitingTherapeutic confirmatory (Phase III)
Graft vs Host Disease Prophylaxis in unrelated donor transplantation: a randomized clinical trial comparing PTCY vs ATG
This study compares two ways to prevent a serious complication called graft-versus-host disease (GvHD) after a certain type of blood stem cell transplant. It aims to find out which method helps people live longer and stay healthier after their transplant.
Germany